Search

Search Constraints

You searched for: Author/Creator Fujioka, Ken

Search Results

1. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Issue 10077 (8th April 2017)

3. A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. Issue 2 (13th November 2018)

6. Early weight loss responders to liraglutide 3.0 mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes. Issue 1 (January 2019)

7. Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers. Issue 11 (November 2016)

8. Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12‐Week Treatment: A Randomized Substudy. Issue 2 (24th January 2018)

10. Erratum: A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. Issue 7 (13th May 2019)